Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Reduce” by Analysts

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been assigned a consensus recommendation of “Reduce” from the six ratings firms that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $1.80.

Separately, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Aveanna Healthcare from $2.00 to $3.00 and gave the company a “buy” rating in a research report on Monday, March 18th.

Aveanna Healthcare Stock Performance

Aveanna Healthcare stock opened at $2.40 on Friday. The company has a market cap of $461.71 million, a P/E ratio of -3.38 and a beta of 2.03. Aveanna Healthcare has a 1-year low of $0.85 and a 1-year high of $3.00. The company has a fifty day simple moving average of $2.41 and a 200 day simple moving average of $2.16.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, March 14th. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. The business had revenue of $478.84 million during the quarter, compared to the consensus estimate of $464.33 million. On average, equities research analysts forecast that Aveanna Healthcare will post -0.13 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of AVAH. Envestnet Asset Management Inc. grew its position in shares of Aveanna Healthcare by 15.7% in the 1st quarter. Envestnet Asset Management Inc. now owns 26,363 shares of the company’s stock valued at $90,000 after acquiring an additional 3,569 shares during the period. Swiss National Bank lifted its stake in shares of Aveanna Healthcare by 7.4% during the 1st quarter. Swiss National Bank now owns 108,800 shares of the company’s stock worth $371,000 after buying an additional 7,500 shares during the last quarter. Natixis Advisors L.P. lifted its stake in shares of Aveanna Healthcare by 18.0% during the 1st quarter. Natixis Advisors L.P. now owns 415,964 shares of the company’s stock worth $1,419,000 after buying an additional 63,365 shares during the last quarter. MetLife Investment Management LLC lifted its stake in shares of Aveanna Healthcare by 54.9% during the 1st quarter. MetLife Investment Management LLC now owns 28,914 shares of the company’s stock worth $99,000 after buying an additional 10,246 shares during the last quarter. Finally, BlackRock Inc. lifted its stake in shares of Aveanna Healthcare by 2.3% during the 1st quarter. BlackRock Inc. now owns 3,087,209 shares of the company’s stock worth $10,526,000 after buying an additional 69,609 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.